Literature DB >> 21508163

Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein.

Jay Lucidarme1, Lionel Tan, Rachel M Exley, Jamie Findlow, Ray Borrow, Christoph M Tang.   

Abstract

Neisseria meningitidis remains a leading cause of bacterial sepsis and meningitis. Complement is a key component of natural immunity against this important human pathogen, which has evolved multiple mechanisms to evade complement-mediated lysis. One approach adopted by the meningococcus is to recruit a human negative regulator of the complement system, factor H (fH), to its surface via a lipoprotein, factor H binding protein (fHbp). Additionally, fHbp is a key antigen in vaccines currently being evaluated in clinical trials. Here we characterize strains of N. meningitidis from several distinct clonal complexes which do not express fHbp; all strains were recovered from patients with disseminated meningococcal disease. We demonstrate that these strains have either a frameshift mutation in the fHbp open reading frame or have entirely lost fHbp and some flanking sequences. No fH binding was detected to other ligands among the fHbp-negative strains. The implications of these findings for meningococcal pathogenesis and prevention are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508163      PMCID: PMC3122619          DOI: 10.1128/CVI.00055-11

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  52 in total

Review 1.  Complement regulators and inhibitory proteins.

Authors:  Peter F Zipfel; Christine Skerka
Journal:  Nat Rev Immunol       Date:  2009-09-04       Impact factor: 53.106

2.  Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium.

Authors:  Thomas C Sutherland; Paola Quattroni; Rachel M Exley; Christoph M Tang
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

3.  Comparative genome biology of a serogroup B carriage and disease strain supports a polygenic nature of meningococcal virulence.

Authors:  Biju Joseph; Susanne Schneiker-Bekel; Anja Schramm-Glück; Jochen Blom; Heike Claus; Burkhard Linke; Roland F Schwarz; Anke Becker; Alexander Goesmann; Matthias Frosch; Christoph Schoen
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

4.  Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005.

Authors:  Lee H Harrison; Kathleen A Shutt; Susanna E Schmink; Jane W Marsh; Brian H Harcourt; Xin Wang; Anne M Whitney; David S Stephens; Amanda A Cohn; Nancy E Messonnier; Leonard W Mayer
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

5.  Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease.

Authors:  Sonia Davila; Victoria J Wright; Chiea Chuen Khor; Kar Seng Sim; Alexander Binder; Willemijn B Breunis; David Inwald; Simon Nadel; Helen Betts; Enitan D Carrol; Ronald de Groot; Peter W M Hermans; Jan Hazelzet; Marieke Emonts; Chui Chin Lim; Taco W Kuijpers; Federico Martinon-Torres; Antonio Salas; Werner Zenz; Michael Levin; Martin L Hibberd
Journal:  Nat Genet       Date:  2010-08-08       Impact factor: 38.330

6.  The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease.

Authors:  Elisabeth Kugelberg; Bridget Gollan; Christopher Farrance; Holly Bratcher; Jay Lucidarme; Ana Belén Ibarz-Pavón; Martin C J Maiden; Ray Borrow; Christoph M Tang
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

7.  Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales.

Authors:  Jay Lucidarme; Maurizio Comanducci; Jamie Findlow; Stephen J Gray; Edward B Kaczmarski; Malcolm Guiver; Elisabeth Kugelberg; Pamela J Vallely; Philipp Oster; Mariagrazia Pizza; Stefania Bambini; Alessandro Muzzi; Christoph M Tang; Ray Borrow
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

8.  The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement.

Authors:  Lisa A Lewis; Jutamas Ngampasutadol; Ruth Wallace; Jane E A Reid; Ulrich Vogel; Sanjay Ram
Journal:  PLoS Pathog       Date:  2010-07-29       Impact factor: 6.823

9.  NeMeSys: a biological resource for narrowing the gap between sequence and function in the human pathogen Neisseria meningitidis.

Authors:  Christophe Rusniok; David Vallenet; Stéphanie Floquet; Helen Ewles; Coralie Mouzé-Soulama; Daniel Brown; Aurélie Lajus; Carmen Buchrieser; Claudine Médigue; Philippe Glaser; Vladimir Pelicic
Journal:  Genome Biol       Date:  2009-10-09       Impact factor: 13.583

10.  Variation of the factor H-binding protein of Neisseria meningitidis.

Authors:  Carina Brehony; Daniel J Wilson; Martin C J Maiden
Journal:  Microbiology (Reading)       Date:  2009-09-03       Impact factor: 2.777

View more
  33 in total

1.  The relative roles of factor H binding protein, neisserial surface protein A, and lipooligosaccharide sialylation in regulation of the alternative pathway of complement on meningococci.

Authors:  Lisa A Lewis; Matthew Carter; Sanjay Ram
Journal:  J Immunol       Date:  2012-04-13       Impact factor: 5.422

2.  Expression of factor H binding protein in meningococcal strains can vary at least 15-fold and is genetically determined.

Authors:  Massimiliano Biagini; Marco Spinsanti; Gabriella De Angelis; Sara Tomei; Ilaria Ferlenghi; Maria Scarselli; Fabio Rigat; Nicola Messuti; Alessia Biolchi; Alessandro Muzzi; Giulia Anderloni; Brunella Brunelli; Elena Cartocci; Francesca Buricchi; Chiara Tani; Maria Stella; Monica Moschioni; Elena Del Tordello; Annalisa Colaprico; Silvana Savino; Marzia M Giuliani; Isabel Delany; Mariagrazia Pizza; Paolo Costantino; Nathalie Norais; Rino Rappuoli; Vega Masignani
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-17       Impact factor: 11.205

3.  Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model.

Authors:  Lisa A Lewis; David M Vu; Dan M Granoff; Sanjay Ram
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

4.  Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica.

Authors:  Jay Lucidarme; Stefanie Gilchrist; Lynne S Newbold; Stephen J Gray; Edward B Kaczmarski; Lynne Richardson; Julia S Bennett; Martin C J Maiden; Jamie Findlow; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2013-06-26

Review 5.  The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.

Authors:  Davide Serruto; Matthew J Bottomley; Sanjay Ram; Marzia M Giuliani; Rino Rappuoli
Journal:  Vaccine       Date:  2012-05-30       Impact factor: 3.641

6.  Molecular Engineering of Ghfp, the Gonococcal Orthologue of Neisseria meningitidis Factor H Binding Protein.

Authors:  Valentina Rippa; Laura Santini; Paola Lo Surdo; Francesca Cantini; Daniele Veggi; Maria Antonietta Gentile; Eva Grassi; Giulia Iannello; Brunella Brunelli; Francesca Ferlicca; Emiliano Palmieri; Michele Pallaoro; Beatrice Aricò; Lucia Banci; Mariagrazia Pizza; Maria Scarselli
Journal:  Clin Vaccine Immunol       Date:  2015-05-06

7.  fH-dependent complement evasion by disease-causing meningococcal strains with absent fHbp genes or frameshift mutations.

Authors:  Serena Giuntini; David M Vu; Dan M Granoff
Journal:  Vaccine       Date:  2013-06-17       Impact factor: 3.641

Review 8.  Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?

Authors:  Dan M Granoff; Sanjay Ram; Peter T Beernink
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

9.  Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.

Authors:  Raffaella Rossi; Monica Konar; Peter T Beernink
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

10.  ZnuD, a potential candidate for a simple and universal Neisseria meningitidis vaccine.

Authors:  Kerstin Hubert; Nathalie Devos; Ines Mordhorst; Christine Tans; Guy Baudoux; Christiane Feron; Karine Goraj; Jan Tommassen; Ulrich Vogel; Jan T Poolman; Vincent Weynants
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.